Works matching IS 01615505 AND DT 2019 AND VI 60 AND IP 12


Results: 301
    1
    2

    Long term follow-up and outcomes of re-treatment in an expanded 50 patient single-center phase II prospective trial of Lutetium-177 (177Lu) PSMA-617 theranostics in metastatic castrate-resistant prostate cancer.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236414
    By:
    • Violet, John;
    • Sandhu, Shahneen;
    • Iravani, Amir;
    • Ferdinandus, Justin;
    • Thang, Sue-Ping;
    • Kong, Grace;
    • Kumar, Aravind Ravi;
    • Akhurst, Tim;
    • Pattison, David;
    • Beaulieu, Alexis;
    • Mooi, Jennifer;
    • Tran, Ben;
    • Guo, Christina;
    • Kalff, Victor;
    • Murphy, Declan G;
    • Jackson, Price;
    • Eu, Peter;
    • Scalzo, Mark;
    • Williams, Scott;
    • Hicks, Rodney J.
    Publication type:
    Article
    3
    4
    5

    Evaluation of dosimetry, quantitative methods and test-retest variability of <sup>18</sup>F-PI-2620 PET for the assessment of tau deposits in the human brain.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236240
    By:
    • Bullich, Santiago;
    • Barret, Olivier;
    • Constantinescu, Cristian;
    • Sandiego, Christine;
    • Mueller, Andre;
    • Berndt, Mathias;
    • Papin, Caroline;
    • Perrotin, Audrey;
    • Koglin, Norman;
    • Kroth, Heiko;
    • Pfeifer, Andrea;
    • Tamagnan, Gilles;
    • Madonia, Jennifer;
    • Seibyl, John P.;
    • Marek, Kenneth;
    • Santi, Susan de;
    • Dinkelborg, Ludger M.;
    • Stephens, Andrew W.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Inflammation-based index and <sup>68</sup>Ga-DOTATOC PET-derived uptake and volumetric parameters predict outcome in neuroendocrine tumor patients treated with <sup> 90</sup>Y-DOTATOC.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236935
    By:
    • Pauwels, Elin;
    • Binnebeek, Sofie Van;
    • Vandecaveye, Vincent;
    • Baete, Kristof;
    • Vanbilloen, Hubert;
    • Koole, Michel;
    • Mottaghy, Felix M.;
    • Haustermans, Karin;
    • Clement, Paul M.;
    • Nackaerts, Kristiaan;
    • Cutsem, Eric Van;
    • Verslype, Chris;
    • Deroose, Christophe M.
    Publication type:
    Article
    15
    16

    Tau PET imaging with <sup>18</sup>F-PI-2620 in patients with Alzheimer’s disease and healthy controls: a first-in-human study.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236224
    By:
    • Mueller, Andre;
    • Bullich, Santiago;
    • Barret, Olivier;
    • Madonia, Jennifer;
    • Berndt, Mathias;
    • Papin, Caroline;
    • Perrotin, Audrey;
    • Koglin, Norman;
    • Kroth, Heiko;
    • Pfeifer, Andrea;
    • Tamagnan, Gilles;
    • Seibyl, John P.;
    • Marek, Kenneth;
    • Santi, Susan de;
    • Dinkelborg, Ludger M.;
    • Stephens, Andrew W.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22

    Intraindividual comparison of <sup>18</sup>F‐PSMA‐1007 with renally excreted PSMA ligands for PSMA‐PET imaging in patients with relapsed prostate cancer.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234898
    By:
    • Dietlein, Felix;
    • Kobe, Carsten;
    • Hohberg, Melanie;
    • Zlatopolskiy, Boris D.;
    • Krapf, Philipp;
    • Endepols, Heike;
    • Täger, Philipp;
    • Hammes, Jochen;
    • Heidenreich, Axel;
    • Persigehl, Thorsten;
    • Neumaier, Bernd;
    • Drzezga, Alexander;
    • Dietlein, Markus
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    <sup>18</sup>F-DCFPyL-PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234799
    By:
    • Mena, Esther;
    • Lindenberg, Maria Liza;
    • Turkbey, Ismail Baris;
    • Shih, Joanna H.;
    • Harmon, Stephanie A.;
    • Lim, Ilhan;
    • Lin, Frank;
    • Adler, Stephen;
    • Eclarinal, Philip;
    • McKinney, Yolanda L.;
    • Citrin, Deborah;
    • Dahut, William;
    • Wood, Bradford J.;
    • Krishnasamy, Venkatesh;
    • Chang, Richard;
    • Levy, Elliot;
    • Merino, Maria;
    • Pinto, Peter;
    • Eary, Janet F.;
    • Choyke, Peter L.
    Publication type:
    Article
    30
    31

    Mapping prostate cancer lesions pre/post unsuccessful salvage lymph node dissection using repeat PSMA-PET.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.235374
    By:
    • Farolfi, Andrea;
    • Ilhan, Harun;
    • Gafita, Andrei;
    • Calais, Jeremie;
    • Barbato, Francesco;
    • Weber, Manuel;
    • Afshar-Oromieh, Ali;
    • Spohn, Fabian;
    • Wetter, Axel;
    • Rischpler, Christoph;
    • Hadaschik, Boris;
    • Pianori, Davide;
    • Fanti, Stefano;
    • Haberkorn, Uwe;
    • Eiber, Matthias;
    • Herrmann, Ken;
    • Fendler, Wolfgang Peter
    Publication type:
    Article
    32
    33

    3 year freedom from progression following <sup>68</sup>GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a prospective multi‐center trial.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.235028
    By:
    • Emmett, Louise;
    • Tang, Reuben;
    • Nandurkar, Rohan;
    • Hruby, George;
    • Roach, Paul;
    • Watts, Jo Anne;
    • Cusick, Thomas;
    • Kneebone, Andrew;
    • Bao Ho;
    • Chan, Lyn;
    • van Leeuwen, Pim J.;
    • Scheltema, Matthijs J.;
    • Nguyen, Andrew;
    • Charlotte Yin;
    • Scott, Andrew;
    • Tang, Colin;
    • McCarthy, Michael;
    • Fullard, Karen;
    • Roberts, Matthew;
    • Francis, Roslyn
    Publication type:
    Article
    34
    35
    36
    37

    1Histologically-confirmed diagnostic efficacy of <sup>18</sup>F-rhPSMA-7 positron emission tomography for N-staging of patients with primary high risk prostate cancer.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234906
    By:
    • Kroenke, Markus;
    • Wurzer, Alexander;
    • Schwamborn, Kristina;
    • Ulbrich, Lena;
    • Jooß, Lena;
    • Maurer, Tobias;
    • Horn, Thomas;
    • Rauscher, Isabel;
    • Haller, Bernhard;
    • Herz, Michael;
    • Wester, Hans-Jürgen;
    • Weber, Wolfgang A.;
    • Eiber, Matthias
    Publication type:
    Article
    38

    Patients resistant against PSMA-targeting alpha-radiation therapy often harbor mutations in DNA-repair associated genes.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234559
    By:
    • Kratochwil, Clemens;
    • Giesel, Frederik L.;
    • Heussel, Claus-Peter;
    • Kazdal, Daniel;
    • Endris, Volker;
    • Nientiedt, Cathleen;
    • Bruchertseifer, Frank;
    • Kippenberger, Maximilian;
    • Rathke, Hendrik;
    • Leichsenring, Jonas;
    • Hohenfellner, Markus;
    • Morgenstern, Alfred;
    • Haberkorn, Uwe;
    • Duensing, Stefan;
    • Stenzinger, Albrecht
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50